Workhorse Group WHKS stock analysis & is WKHS stock a good investment

Twist, Ono partner to develop antibodies for autoimmune diseases

Twist and Ono will discover and develop novel antibodies to treat autoimmune diseases. Credit: ustas7777777 / Shutterstock.com. Twist Bioscience and Ono Pharmaceutical have signed a

September 1, 2023

Adjuvant Immunotherapy in Early-Stage NSCLC

Adjuvant chemotherapy has been the standard of care for patients with resectable non-small cell lung cancer (NSCLC), but newer therapies are entering the mix as

June 30, 2023

Direct to consumer channels change patient-healthcare system relationship – Pharmaceutical Technology

From left to right: moderator Oliver Barnes, US Pharmaceutical and Biotech Correspondent, Financial Times; Eden Wells, Chief Insights and Decision Science Officer, Novartis; Amy West,

May 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.